Brief: Bionik Laboratories Reports Q3 2021 Financial Results
11/02/2021 13:28
Feb 11 (Reuters) - Bionik Laboratories Corp BNKL.PK :
* BIONIK LABORATORIES REPORTS FISCAL 2021 Q3 FINANCIAL
RESULTS
* Q3 REVENUE $180,000
* Q3 NON-GAAP LOSS PER SHARE $0.34
* Q3 LOSS PER SHARE $1.75
Source text for Eikon: ID:nBw9Dyl4Va
Further company coverage: BNKL.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionik Laboratories
See all newsBrief: Bionik Laboratories Reports A Significant Increase In Patient Volume At Its Acquired Rehabilitation Center In Florida
Brief: Bionik Laboratories Enters Into Distribution Agreement With Pro-Med Technology For The Sale Of Inmotion® Robotic Devices In Hong Kong
Brief: Bionik Laboratories acquires Florida Rehabilitation Center first in strategic national rollout
Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
Brief: Bionik Laboratories Says Chief Commercial Officer, Terminated Other Than For Cause From Employment, Officer Positions With Co, Units